Akamai (NASDAQ: AKAM) CTO gains 7,906 shares, 2,262 withheld

Rhea-AI Filing Summary

Akamai Technologies Chief Technology Officer Robert Blumofe reported multiple equity award updates tied to performance goals. On February 19, 2026, 3,152 additional performance restricted stock units (PRSUs) were earned from a 2023 grant, leading to vesting of a total of 7,906 PRSUs that each convert into one share of common stock. Additional PRSUs of 2,154 from a 2024 grant and 3,262 from a 2025 grant were also earned based on 2025 financial results, with future vesting dependent on meeting performance targets in later years. These PRSUs were exercised into 7,906 shares of common stock, and 2,262 shares of common stock were disposed of at $109.31 per share to cover tax obligations. After these transactions, Blumofe directly holds 20,218 shares of Akamai common stock and indirectly holds 114.095 shares through a 401(k) plan.

Insights

Equity Compensation Analyst

Equity awards vested and taxes were covered via share withholding, with no open-market selling.

The transactions show Robert Blumofe earning and vesting performance restricted stock units as Akamai’s financial targets are certified. A 2023 PRSU grant yielded an additional 3,152 units, leading to vesting and conversion of 7,906 units into common shares.

Further PRSUs from 2024 and 2025 grants, totaling 2,154 and 3,262 units, were earned for 2025 performance and remain subject to future year targets. To satisfy tax obligations, 2,262 common shares were used at $109.31 per share, a standard tax-withholding disposition rather than an open-market sale.

Following these actions as of February 19, 2026, Blumofe directly owns 20,218 Akamai shares and indirectly holds 114.095 shares via a 401(k) plan. These movements primarily reflect routine executive compensation mechanics rather than a directional view on the stock.

Insider Trade Summary

7,906 shares exercised/converted

Mixed 7 txns

Insider Blumofe Robert

Role Chief Technology Officer

Type	Security	Shares	Price	Value
Grant/Award	Performance Restricted Stock Units	3,152	$0.00	--
Exercise	Performance Restricted Stock Units	7,906	$0.00	--
Grant/Award	Performance Restricted Stock Units	2,154	$0.00	--
Grant/Award	Performance Restricted Stock Units	3,262	$0.00	--
Exercise	Common Stock	7,906	$0.00	--
Tax Withholding	Common Stock	2,262	$109.31	$247K
holding	Common Stock	--	--	--

Holdings After Transaction: Performance Restricted Stock Units — 7,906 shares (Direct); Common Stock — 22,480 shares (Direct); Common Stock — 114.095 shares (Indirect, By 401(k) Plan)

Footnotes (1)

1. Represents an award of performance restricted stock units ("PRSUs") originally granted to the Reporting Person on March 6, 2023 contingent upon achievement of specified financial performance targets for each of 2023, 2024 and 2025. Each PRSU represents the right to receive one share of Issuer common stock upon vesting. On February 19, 2026, the Issuer's financial results for 2025 were certified, resulting in an additional 3,152 shares being earned and the vesting of a total of 7,906 shares of Issuer common stock subject to such PRSUs. As of February 19, 2026. Represents an award of PRSUs originally granted to the Reporting Person on March 4, 2024 contingent upon achievement of specified financial performance targets for each of 2024, 2025 and 2026. Each PRSU represents the right to receive one share of Issuer common stock upon vesting. On February 19, 2026, the Issuer's financial results for 2025 were certified, resulting in an additional 2,154 shares being earned. To the extent the targets for each such year are met, the PRSUs will fully vest on the date on which the Issuer's financial results for 2026 are certified. Represents an award of PRSUs originally granted to the Reporting Person on March 3, 2025 contingent upon achievement of specified financial performance targets for each of 2025, 2026 and 2027. Each PRSU represents the right to receive one share of Issuer common stock upon vesting. On February 19, 2026, the Issuer's financial results for 2025 were certified, resulting in 3,262 shares being earned. To the extent the targets for each such year are met, the PRSUs will fully vest on the date on which the Issuer's financial results for 2027 are certified.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Accepted by SEC EDGAR 02/20/2026 - 05:44 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Blumofe Robert

(Last) (First) (Middle)

C/O AKAMAI TECHNOLOGIES, INC.

145 BROADWAY

(Street)

CAMBRIDGE MA 02142

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
AKAMAI TECHNOLOGIES INC [ AKAM ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Technology Officer

3. Date of Earliest Transaction (Month/Day/Year)
02/19/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	02/19/2026		M		7,906	A	(1)	22,480	D
Common Stock	02/19/2026		F		2,262	D	$109.31	20,218	D
Common Stock								114.095(2)	I	By 401(k) Plan

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Performance Restricted Stock Units	(1)	02/19/2026		A		3,152		(1)	(1)	Common Stock	3,152	$0	7,906	D
Performance Restricted Stock Units	(1)	02/19/2026		M			7,906	(1)	(1)	Common Stock	7,906	$0	0	D
Performance Restricted Stock Units	(3)	02/19/2026		A		2,154		(3)	(3)	Common Stock	2,154	$0	3,279	D
Performance Restricted Stock Units	(4)	02/19/2026		A		3,262		(4)	(4)	Common Stock	3,262	$0	3,262	D

Explanation of Responses:

1. Represents an award of performance restricted stock units ("PRSUs") originally granted to the Reporting Person on March 6, 2023 contingent upon achievement of specified financial performance targets for each of 2023, 2024 and 2025. Each PRSU represents the right to receive one share of Issuer common stock upon vesting. On February 19, 2026, the Issuer's financial results for 2025 were certified, resulting in an additional 3,152 shares being earned and the vesting of a total of 7,906 shares of Issuer common stock subject to such PRSUs.

2. As of February 19, 2026.

3. Represents an award of PRSUs originally granted to the Reporting Person on March 4, 2024 contingent upon achievement of specified financial performance targets for each of 2024, 2025 and 2026. Each PRSU represents the right to receive one share of Issuer common stock upon vesting. On February 19, 2026, the Issuer's financial results for 2025 were certified, resulting in an additional 2,154 shares being earned. To the extent the targets for each such year are met, the PRSUs will fully vest on the date on which the Issuer's financial results for 2026 are certified.

4. Represents an award of PRSUs originally granted to the Reporting Person on March 3, 2025 contingent upon achievement of specified financial performance targets for each of 2025, 2026 and 2027. Each PRSU represents the right to receive one share of Issuer common stock upon vesting. On February 19, 2026, the Issuer's financial results for 2025 were certified, resulting in 3,262 shares being earned. To the extent the targets for each such year are met, the PRSUs will fully vest on the date on which the Issuer's financial results for 2027 are certified.

Remarks:

	/s/ Thomas M. Lair, as power of attorney	02/20/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transactions did Akamai (AKAM) CTO Robert Blumofe report?

Robert Blumofe reported vesting and exercise of performance restricted stock units into 7,906 Akamai common shares, plus new PRSUs earned from 2024 and 2025 grants. He also reported a tax-withholding disposition of 2,262 shares at $109.31 per share.

How many Akamai shares did Robert Blumofe acquire through PRSUs?

Blumofe had 7,906 performance restricted stock units vest and convert into the same number of Akamai common shares. These units came from a 2023 PRSU grant tied to financial performance targets that were certified based on the company’s 2025 results.

Why did Akamai CTO Robert Blumofe dispose of 2,262 shares?

Blumofe disposed of 2,262 Akamai common shares at $109.31 per share to cover tax liabilities related to equity vesting. This transaction is coded as a tax-withholding disposition, indicating it was not an open-market sale for investment purposes.

What is Robert Blumofe’s Akamai share ownership after these Form 4 transactions?

After these transactions, Blumofe directly owns 20,218 shares of Akamai common stock. In addition, he indirectly holds 114.095 shares through a 401(k) plan, reflecting retirement-plan holdings separate from his direct stock ownership.

How are Akamai PRSU awards structured for Robert Blumofe?

Blumofe’s PRSUs from 2023, 2024, and 2025 grants each convert into one Akamai share upon vesting, contingent on multi-year financial performance targets. Portions were earned when 2025 results were certified, with remaining units vesting after future years’ performance is certified.

Did Akamai CTO Robert Blumofe make any open-market stock purchases or sales?

The reported transactions show PRSU grants, vesting, and exercises, plus a tax-withholding share disposition. The Form 4 does not show open-market purchases or discretionary sales; the activity reflects equity compensation mechanics and related tax coverage.